Lv11
60 积分 2023-01-11 加入
Unveiling the Mechanism of Lurbinectedin's Action and Its Potential in Combination Therapies in Small Cell Lung Cancer
3小时前
已完结
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity
8天前
已完结
Design, synthesis, and biological evaluation of cathepsin B cleavage albumin-binding SN38 prodrug in breast cancer
12天前
已完结
P3.13D.01 Proteomic Characterization of Antibody Drug Conjugate Target Expression Profiles in Small Cell Lung Cancer (SCLC)
13天前
已完结
B7-H3 Regulates Glucose Metabolism in Neuroblastom via Stat3/c-Met Pathway
14天前
已完结
Controlled loading of albumin-drug conjugates ex vivo for enhanced drug delivery and antitumor efficacy
15天前
已完结
Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
18天前
已完结
Albumin-based delivery systems: Recent advances, challenges, and opportunities
18天前
已完结
A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)-design and rationale
21天前
已完结
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL)
21天前
已完结
皖公网安备34019202002308
